These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 2174781

  • 1. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jollès P, Caen J.
    Eur J Biochem; 1990 Nov 26; 194(1):43-9. PubMed ID: 2174781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
    Leveugle B, Mazurier J, Legrand D, Mazurier C, Montreuil J, Spik G.
    Eur J Biochem; 1993 May 01; 213(3):1205-11. PubMed ID: 8389297
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
    Bennett JS, Shattil SJ, Power JW, Gartner TK.
    J Biol Chem; 1988 Sep 15; 263(26):12948-53. PubMed ID: 3417645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK, Bennett JS.
    J Biol Chem; 1985 Oct 05; 260(22):11891-4. PubMed ID: 2995350
    [Abstract] [Full Text] [Related]

  • 15. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA, Bozarth J, Forsythe M, Tsao P, Pease L, Reilly TM.
    Life Sci; 1994 Oct 05; 54(16):1155-62. PubMed ID: 8152339
    [Abstract] [Full Text] [Related]

  • 16. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS, Panzer-Knodle SG, Salyers AK, Taite BB, King LW, Miyano M, Gorczynski RJ, Williams MH, Zupec ME, Tjoeng FS.
    J Pharmacol Exp Ther; 1991 Mar 15; 256(3):876-82. PubMed ID: 2005585
    [Abstract] [Full Text] [Related]

  • 20. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC, McLane MA, Trybulec M, Kowalska MA, Khan S, Budzynski AZ, Niewiarowski S.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):118-24. PubMed ID: 8422238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.